ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Do GPCRs constitute the target of 30% of newly approved drugs in Germany?
Sophia Schröer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it